BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 18329957)

  • 1. Multiple pathways regulated by the tumor suppressor PP2A in transformation.
    Westermarck J; Hahn WC
    Trends Mol Med; 2008 Apr; 14(4):152-60. PubMed ID: 18329957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of PP2A in viral and cellular transformation.
    Arroyo JD; Hahn WC
    Oncogene; 2005 Nov; 24(52):7746-55. PubMed ID: 16299534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SV40 small T antigen and PP2A phosphatase in cell transformation.
    Sablina AA; Hahn WC
    Cancer Metastasis Rev; 2008 Jun; 27(2):137-46. PubMed ID: 18214640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein phosphatase 2A: its structure, function and activity regulation].
    Liu WJ; Shen Y; Ding J
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):105-12. PubMed ID: 12545214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
    Martín-Encabo S; Santos E; Guerrero C
    Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system.
    Boudreau RT; Hoskin DW
    Int Immunopharmacol; 2005 Sep; 5(10):1507-18. PubMed ID: 16023602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of PP2A A subunits in tumor suppression.
    Sablina AA; Hahn WC
    Cell Adh Migr; 2007; 1(3):140-1. PubMed ID: 19262135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein phosphatase 2A regulatory subunits and cancer.
    Eichhorn PJ; Creyghton MP; Bernards R
    Biochim Biophys Acta; 2009 Jan; 1795(1):1-15. PubMed ID: 18588945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression.
    Wong LL; Chang CF; Koay ES; Zhang D
    Int J Oncol; 2009 May; 34(5):1291-301. PubMed ID: 19360341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by tumour antigens defines a role for PP2A in signal transduction.
    Mumby M
    Semin Cancer Biol; 1995 Aug; 6(4):229-37. PubMed ID: 8541518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1.
    Bengtsson L; Schwappacher R; Roth M; Boergermann JH; Hassel S; Knaus P
    J Cell Sci; 2009 Apr; 122(Pt 8):1248-57. PubMed ID: 19339557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of protein phosphatase 2A facilitated an early stage of chemical carcinogenesis.
    Ishii Y; Kuroda K; Matsushita K; Yokoo Y; Takasu S; Kijima A; Nohmi T; Ogawa K; Umemura T
    Toxicol Appl Pharmacol; 2017 Dec; 336():75-83. PubMed ID: 29054680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of autophagy by oncogenes and tumor suppressor genes.
    Maiuri MC; Tasdemir E; Criollo A; Morselli E; Vicencio JM; Carnuccio R; Kroemer G
    Cell Death Differ; 2009 Jan; 16(1):87-93. PubMed ID: 18806760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail).
    Janssens V; Longin S; Goris J
    Trends Biochem Sci; 2008 Mar; 33(3):113-21. PubMed ID: 18291659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic transformation of human cells: shortcomings of rodent model systems.
    Akagi T
    Trends Mol Med; 2004 Nov; 10(11):542-8. PubMed ID: 15519280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3D structure of protein phosphatase 2A: new insights into a ubiquitous regulator of cell signaling.
    Mumby M
    ACS Chem Biol; 2007 Feb; 2(2):99-103. PubMed ID: 17313179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From promiscuity to precision: protein phosphatases get a makeover.
    Virshup DM; Shenolikar S
    Mol Cell; 2009 Mar; 33(5):537-45. PubMed ID: 19285938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.
    Umesalma S; Kaemmer CA; Kohlmeyer JL; Letney B; Schab AM; Reilly JA; Sheehy RM; Hagen J; Tiwari N; Zhan F; Leidinger MR; O'Dorisio TM; Dillon J; Merrill RA; Meyerholz DK; Perl AL; Brown BJ; Braun TA; Scott AT; Ginader T; Taghiyev AF; Zamba GK; Howe JR; Strack S; Bellizzi AM; Narla G; Darbro BW; Quelle FW; Quelle DE
    J Clin Invest; 2019 Mar; 129(4):1641-1653. PubMed ID: 30721156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional importance of PP2A regulatory subunit loss in breast cancer.
    Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
    Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific regulation of protein phosphatase 2A PR72/B'' subunits by calpain.
    Janssens V; Derua R; Zwaenepoel K; Waelkens E; Goris J
    Biochem Biophys Res Commun; 2009 Sep; 386(4):676-81. PubMed ID: 19555667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.